Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, Canada.
Am J Transplant. 2011 Apr;11(4):708-18. doi: 10.1111/j.1600-6143.2010.03339.x. Epub 2010 Nov 29.
We assessed the molecular phenotype of 107 6-week protocol biopsies from human renal allografts, using Affymetrix microarrays. Transcript changes were summarized as nonoverlapping pathogenesis-based transcript sets (PBTs) reflecting inflammation (T cells, macrophages, IFNG effects) and the injury-repair response of the parenchyma, stroma and microcirculation-increased ('injury-up') and decreased ('injury-down') transcripts. The molecular changes were highly correlated with each other, even when all rejection and borderline cases were excluded. Inflammation and injury-down PBTs correlated with histologic inflammation and tubulitis, and the inflammation transcripts were greater in kidneys diagnosed as T cell-mediated or borderline rejection. Injury-up PBTs did not correlate with histopathology but did correlate with kidney function: thus functional disturbances are represented in transcript changes but not in histopathology. PBT changes correlated with prior delayed graft function. However, there was little difference between live donor kidneys and deceased donor kidneys that had not shown delayed graft function. Molecular changes did not predict future biopsies for clinical indications, rejection episodes, functional deterioration or allograft loss. Thus while detecting T cell-mediated inflammation, the molecular phenotype of early protocol biopsies mostly reflects the injury-repair response to implantation stresses, and has little relationship to future events and outcomes.
我们使用 Affymetrix 微阵列评估了 107 例 6 周方案活检的人类肾移植分子表型。转录变化被总结为非重叠的基于发病机制的转录集 (PBT),反映了炎症 (T 细胞、巨噬细胞、IFNG 效应) 和实质、基质和微循环的损伤修复反应 - 增加 ('损伤增加') 和减少 ('损伤减少') 的转录物。即使排除所有排斥和边界病例,分子变化也高度相关。炎症和损伤减少 PBT 与组织学炎症和肾小管炎相关,并且在诊断为 T 细胞介导或边界排斥的肾脏中炎症转录物更大。损伤增加的 PBT 与组织病理学无关,但与肾功能相关:因此,功能障碍在转录变化中得到体现,但在组织病理学中没有体现。PBT 变化与先前的延迟移植物功能有关。然而,对于未表现出延迟移植物功能的活体供体肾脏和已故供体肾脏,差异很小。分子变化不能预测未来用于临床指征、排斥发作、功能恶化或移植物丢失的活检。因此,尽管早期方案活检可以检测到 T 细胞介导的炎症,但分子表型主要反映了对植入应激的损伤修复反应,与未来的事件和结果几乎没有关系。